Jaguar Health, Inc. financial data

Symbol
JAGX on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Pine Street Suite 400, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Jaguar Animal Health, Inc. (to 7/31/2017)
Latest financial report
10-K/A - Q4 2024 - Apr 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 186 % +45.9%
Quick Ratio 50.4 % +26.5%
Return On Equity -0.33 % +61.4%
Return On Assets -0.07 % +12.2%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 28M USD +183%
Weighted Average Number of Shares Outstanding, Basic 295K shares +1810%
Weighted Average Number of Shares Outstanding, Diluted 295K shares +1810%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.11M USD +10.5%
Cost of Revenue 1.96M USD -4.03%
Research and Development Expense 16.5M USD -11%
Selling and Marketing Expense 7.69M USD +19.1%
General and Administrative Expense 16.3M USD -1.55%
Costs and Expenses 42.5M USD -3.48%
Operating Income (Loss) -30.8M USD +10.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -39.3M USD +6.32%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -39.3K USD +6.33%
Earnings Per Share, Basic -131 USD/shares
Earnings Per Share, Diluted -131 USD/shares -4776%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8M USD +23.7%
Accounts Receivable, after Allowance for Credit Loss, Current 1.53M USD -22.4%
Inventory, Net 10.3M USD +12.6%
Assets, Current 32.2M USD +15.1%
Property, Plant and Equipment, Net 464K USD -6.45%
Operating Lease, Right-of-Use Asset 936K USD -20.4%
Intangible Assets, Net (Excluding Goodwill) 18.5M USD -8.14%
Assets 53.4M USD +5.24%
Accounts Payable, Current 5.29M USD +6.27%
Accrued Liabilities, Current 1.91M USD -49.7%
Contract with Customer, Liability, Current 170K USD
Liabilities, Current 19.7M USD +40.9%
Contract with Customer, Liability, Noncurrent 553K USD
Operating Lease, Liability, Noncurrent 686K USD -22.6%
Liabilities 44.4M USD -3.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -467K USD +28.4%
Retained Earnings (Accumulated Deficit) -346M USD -12.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.49M USD +32.6%
Liabilities and Equity 53.4M USD +5.24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.05M USD +29.1%
Net Cash Provided by (Used in) Financing Activities 12.3M USD -34.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares, Issued 25.9M shares -20.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.2M USD -41.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8M USD +23.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 9K USD +50%
Deferred Tax Assets, Valuation Allowance 93.6M USD +66.4%
Deferred Tax Assets, Gross 94.1M USD +63.3%
Operating Lease, Liability 985K USD -20.2%
Payments to Acquire Property, Plant, and Equipment 0 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -38.3M USD +7.18%
Lessee, Operating Lease, Liability, to be Paid 1.61M USD -22%
Property, Plant and Equipment, Gross 977K USD +1.67%
Operating Lease, Liability, Current 299K USD -14.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 455K USD +31.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 314K USD +3.63%
Operating Lease, Weighted Average Discount Rate, Percent 0.21 pure -4.69%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 624K USD -24.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 266K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 77.7M USD +49.9%
Preferred Stock, Shares Issued 99 shares -44.4%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 77K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 233K USD 0%
Operating Lease, Payments 336K USD +534%
Preferred Stock, Shares Outstanding 99 shares -44.4%
Amortization of Intangible Assets 1.9M USD -5%
Depreciation, Depletion and Amortization 501K USD -0.6%
Deferred Tax Assets, Net of Valuation Allowance 545K USD -61.4%
Share-based Payment Arrangement, Expense 1.64M USD -22.3%
Interest Expense 231K USD -96.4%